BioHarvest Sciences Inc. Common Stock (BHST) Stock Price
BHSTStock
$2.02−46.88%52W
Market Cap$45.79M
P/E—
PEG Ratio—
Div yield—
Beta-0.34
BHST Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-21.65%
Price vs S&P 500 (4W)-0.97%
VGM Score56.74
BHST Earnings Surprise History
Q2 25-0.24est. -0.11
Q3 25-0.14est. -0.12
Q4 25-0.10est. -0.10
Q1 26-0.11est. -0.12
Q2 26-0.17est. -0.12
BHST Analyst Recommendations
Jan 2025
Feb 2025
Mar 2025
Apr 2025
4.14
4.13
4.13
4.13
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BHSTBioHarvest Sciences Inc. Common Stock | C | A | D | $2.02 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences owns patented technology for large-scale plant cell cultivation that produces active plant ingredients directly, without growing whole plants. The company operates across two segments: nutraceuticals such as dietary supplements and botanical-derived Active Pharmaceutical Ingredients for therapeutic use. This platform approach offers potential advantages in production scalability and supply chain efficiency.